Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure

Journal of the American Society of Nephrology

Volumn 8, Issue 9, 1997, Pages 1423-1430

  Heimbürger, Olof ^a   Lönnqvist, Fredrik ^a   Danielsson, Anders ^a   Nordenström, Jörgen ^b   Stenvinkel, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LEPTIN;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOREACTIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL PARAMETERS; OBESITY; PRIORITY JOURNAL;

EID: 0142203432     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Zhang Y, Proenca R, Maffei M, Barone M, Lori L, Friedman JM: Positional cloning of the mouse gene and its human homologue. Nature 372: 425-432, 1994
2. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S: Leptin levels in human and rodent: Measurement of plasma leptin and obRNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161, 1995
3. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295, 1996
4. Haalas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reduction effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995
5. Lönnqvist F, Arner P, Nordfors L, Schalling M: Overexpression of the obese (ob) gene in human subjects. Nat Med 1: 950-953, 1996
6. Lönnqvist F, Wennlund A, Arner P: Relationship between circulating leptin and peripheral fat distribution in obese subjects. Int J Obes Relat Metab Disord 21:255-260, 1997
7. Young GA, Kopple JD, Lindholm B: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 17: 462-471, 1991
8. Marckmann P: Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 29: 75-78, 1988
9. Degoulet P, Legrain M, Réach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Nephron 31: 103-110, 1982
10. CANADA-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7: 198-207, 1996
11. Heimbürger O, Lindholm B, Bergström J: Nutritional effects and management of chronic peritoneal dialysis. In: Nutritional Management of Renal Disease, edited by Kopple JD, Massry S, Baltimore, Williams & Wilkins, 1997, pp 619-668
12. Lopes-Virella MF, Stone P, Ellis S, Coldwell JA: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23: 882-884, 1977
13. Merabet E, Dagogo-Jack S, Coyne W, Klein S, Santiago JV, Hmiel P, Landt M: Increased leptin concentrations in end-stage renal disease. J Clin Endocrinol Metab 82: 847-850, 1997
14. Sharma K, Considine RV, Beckie M, Dunn SR, Weisberg LS, Kurnick BRC, Kurnick PB, O'Connor J, Sinha M, Caro JF: Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51: 1980-1985, 1997
15. Caro J, Kolazcynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV: Decreased cerebrospinal fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348: 159-161, 1996
16. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte DJ: Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nat Med 2: 589-591, 1996
17. Mazess RB, Barden HS, Bisek JP, Hansen J: Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51: 1106-1112, 1990
18. Jebb SA, Elia M: Techniques for the measurement of body composition: A practical guide. Int J Obes Relat Metab Disord 17: 611-621, 1993
19. Abrahamsen B, Hansen TB, Høgsberg IM, Pedersen FB, Beck-Nielsen H: Impact of hemodialysis on dual X-ray absorptiometry, bioelectrical impedance measurements, and anthropometry. Am J Clin Nutr 63: 80-86, 1996
20. Kerr PG, Strauss BJG, Atkins RC: Assessment of the nutritional state of dialysis patients. Blood Purif 14: 382-387, 1996
21. Woodrow G, Oldroyd B, Turney JH, Tompkins L, Brownjohn AM, Smith MA: Whole body and regional body composition in patients with chronic renal failure. Nephrol Dial Transplant 11: 1613-1618, 1996
22. Dinarello CA, Roubenhoff RA: Mechanisms of loss of lean body mass in patients on chronic dialysis. Blood Purif 14: 388-394, 1996
23. Shaldon S, Koch KM, Quellhorst E, Lonneman G, Dinarello CA: CAPD is a second-class treatment. Contrib Nephrol 44: 163-172, 1985
24. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold KR: Endotoxin and cytokines induce expression of leptin, the ob gene product in hamsters: A role for leptin in the anorexia of infection. J Clin Invest 97: 2152-2157, 1996
25. Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ III, Flier JS, Lowell BB, Fraker DL, Alexander HR: Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med 185: 171-175, 1997
26. Pereira BJG, Poutsiaka DD, King AJ, Strom JA, Narayan G, Levey AS, Dinarello CA: In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 42: 1419-1424, 1992
27. Ghysen J, De Plaen JF, van Ypersele de Strihou C: The effects of membrane characteristics on tumour necrosis factor kinetics during haemodialysis. Nephrol Dial Transplant 5: 270-274, 1990
28. Pelleymounter AM, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995
29. Ikizler TA, Wingard RL, Sun M, Harvell J, Parker RA, Hakim RM: Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol 7: 2646-2653, 1996
30. Lee P, O'Neal D, Murphy B, Best J: The role of abdominal adiposity and insulin resistance in dyslipidemia of chronic renal failure. Am J Kidney Dis 29: 54-65, 1997
31. Alvestrand A, Mujagic M, Wajngot A, Efendic S: Glucose intolerance in uremic patients: The relative contributions of impaired β-cell function and insulin resistance. Clin Nephrol 31: 175-183, 1989
32. Mak RH, Bettinelli A, Turner C, Haycock GB, Chantier C: The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 60: 229-233, 1985
33. Emilsson V, Liu Y-L, Cawthorne MA, Morton NM, Davenport M: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46: 313-316, 1997
34. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 247: 1185-1188, 1996